Tepilta® Versus Oxetacaine, Antacids and Placebo

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by MEDA Pharma GmbH & Co. KG
Sponsor:
Collaborators:
Trium Analysis Online GmbH
ICON plc
Clinipace Worldwide
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01336530
First received: April 1, 2011
Last updated: April 26, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)